Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xueqing Dou
Observed names:
X Q Dou,
Xue-Qing Dou,
Xue-qing Dou
Institution:
First Affiliated Hospital of Soochow University
Observed institutions:
Chinese Academy of Medical Sciences & Peking Union Medical College,
Soochow University,
Institute of Hematology & Blood Diseases Hospital,
First Affiliated Hospital of Soochow University,
State Key Laboratory of Experimental Hematology
ORCID:
0000-0003-3304-0079
Observed ORCID:
0000-0003-3304-0079
OpenAlex ID:
A5028380149
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML
2025
·
Jing Lu
, Sheng-li Xue
, et al.
·
Blood
·
80
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial
2024
·
Yunfei Chen
, Yanmei Xu
, et al.
·
Signal Transduction and Targeted Therapy
·
46
PDF
Current and emerging treatments for immune thrombocytopenia
2019
·
Xueqing Dou
, Renchi Yang
·
Expert Review of Hematology
·
25
Role of bone marrow‐derived mesenchymal stem cell defects in CD8+CD28– suppressor T‐lymphocyte induction in patients with immune thrombocytopenia and associated mechanisms
2020
·
Huiyuan Li
, Yue Guan
, et al.
·
British Journal of Haematology
·
24
PDF
Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial
2024
·
Jing Lu
, Huiying Qiu
, et al.
·
Journal of Hematology & Oncology
·
23
PDF
Haemophilia care in China: Achievements in the past decade
2020
·
Xueqing Dou
, Man‐Chiu Poon
, et al.
·
Haemophilia
·
23
Patients with haemophilia A with inhibitors in China: a national real‐world analysis and follow‐up
2021
·
Xueqing Dou
, Wei Liu
, et al.
·
British Journal of Haematology
·
17
Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia
2024
·
Qian Wu
, Xiaofei Yang
, et al.
·
Blood Cancer Journal
·
12
PDF
Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China
2022
·
Xueqing Dou
, Wenhui Zhang
, et al.
·
Haemophilia
·
12
Decreased TLR4 expression on monocytes may cause regulatory T cells abnormality in patients with primary immune thrombocytopenia
2017
·
Yating Hao
, Huiyuan Li
, et al.
·
Autoimmunity
·
12
Demographics, clinical profile and treatment landscape of patients with haemophilia B in China
2022
·
Wenhui Zhang
, Xuewen Song
, et al.
·
Haemophilia
·
10
Increased plasma sCXCL16 levels may have a relationship with Th1/Th2 imbalance in primary immune thrombocytopenia
2017
·
Yating Hao
, Yang Li
, et al.
·
Cytokine
·
10
Reduced PTEN involved in primary immune thrombocytopenia via contributing to B cell hyper-responsiveness
2017
·
Shixuan Wang
, Yue Guan
, et al.
·
Molecular Immunology
·
9
IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial
2025
·
Sheng-Li Xue
, Mei-Jing Liu
, et al.
·
Blood Cancer Journal
·
7
Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVAD
2025
·
Jing Lu
, Yu Zhu
, et al.
·
Discover Oncology
·
4
PDF
Venetoclax and Decitabine Compared with Standard Intensive Chemotherapy As Induction Therapy in Newly Diagnosed Acute Myeloid Leukemia: Updated Results of a Multicenter, Randomized, Phase 2b Trial
2024
·
Jing Lu
, Shengli Xue
, et al.
·
Blood
·
2
PDF
Prognostic impact of clonal hematopoiesis mutations at complete molecular remission in acute myeloid leukemia with NPM1 mutation
2024
·
Linlin Wang
, Mingkai Shu
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
2
Efficacy and Safety of Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Immune Thrombocytopenia: A Prospective, Single Centre, Single Arm, Phase I Trial
2023
·
Yunfei Chen
, Xu Yanmei
, et al.
·
Blood
·
2
Acetaminophen, the Active Ingredient of Tylenol, Protects against Peroxynitrite-Induced DNA Damage: A Chemiluminometric and Electron Paramagnetic Resonance Spectrometric Study
2017
·
Xueqing Dou
, Jason Li
, et al.
·
2
Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter study
2025
·
Mingkai Shu
, Wenjing Ding
, et al.
·
Haematologica
·
1
PDF
Prospective Study of Avapritinib in Patients with Relapsed/Refractory or MRD-Positive Core-Binding Factor Acute Myeloid Leukemia with KIT Mutations
2024
·
Xueqing Dou
, Suning Chen
, et al.
·
Blood
·
1
A Phase 2 Study of Olverembatinib for the Treatment of Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
2024
·
Suning Chen
, Depei Wu
, et al.
·
Blood
·
1
PDF
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study
2024
·
Zhiyu Zhang
, Man Qiao
, et al.
·
Bone Marrow Transplantation
·
1
Improved Prevention and Treatment Strategy of Differentiation Syndrome Contribute to Reduce Early Death of Patients with Acute Promyelocytic Leukemia
2023
·
Qian Wu
, De-Pei Wu
, et al.
·
Blood
·
1
PDF
Venetoclax plus Hypomethylating Agents versus Intensive Chemotherapy as Induction Therapy for Newly Diagnosed AML Patients with NPM1/FLT3-ITD/DNMT3A Triple Mutations: A Real-World, Multicenter Analysis Run title: VEN-HMA vs IA as induction therapy for AML patients with NPM1, FLT3-ITD and DNMT3A mutations
2026
·
Linlin Wang
, Yanan Ma
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
35
Citation count:
327
H-index:
10
I10-index:
12
Year
Topic
Type